Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811430 · ClinicalTrials.gov registry record
Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study
A clinical trial, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 49
- Enrollment target
NCT04811430: Completed study, sponsored by Becton, Dickinson and Company.
NCT04811430 is a clinical trial that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04811430 has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the impact of a continuous needle tracking system on the accuracy, speed, and quality of ultrasound-guided peripheral venous catheter insertion.
Primary Outcome
Number of attempts required to properly place a needle tip in the simulated vessel
Interventions
- DEVICE Randomized Traditional
- DEVICE Cue(TM) Needle Tracking Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2019-10-15 |
What the finished NCT04811430 record still lists
NCT04811430 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Randomized Traditional is the first listed.
NCT04811430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04811430 about?
NCT04811430 is a clinical study titled "Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study". The purpose of this study was to assess the impact of a continuous needle tracking system on the accuracy, speed, and quality of ultrasound-guided peripheral venous catheter insertion.
What is the current status of trial NCT04811430?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2019-10-14. Estimated completion is 2019-10-15.
What interventions are being tested in trial NCT04811430?
The interventions under investigation include: Randomized Traditional (DEVICE), Cue(TM) Needle Tracking Technology (DEVICE).
Who is sponsoring clinical trial NCT04811430?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI